Skip to content

A study to validate smart breath analyzer as a screening tool for diabetic, hepatic, renal, lung, lipid and other metabolic disorders

Early identification of metabolic function derangements such as diabetes, liver, renal issues by Humorsâ?? smart breath analyzer and its validation as a screening tool among diseased and healthy controls

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045983
Enrollment
3000
Registered
2022-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E888- Other specified metabolic disorders

Interventions

None listed

Sponsors

Humors Tech Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participant must either be a completely healthy individual as confirmed by blood examination or a known case of diseases in focus such as diabetes, kidney issue, liver issue, lung issue and lipid issue with relevant diagnostics reports tested within 15 days of participation in the study. a. Patients that are known case of Diabetes tested for FBS or RBS within 15 days of participation b. Patients that are known case of kidney related disease tested for RFT within 15 days of participation c. Patients that are known case of liver related disease tested for LFT within 15 days of participation d. Patients that are known case of lung related disease tested by spirometry within 15 days of participation e. Patients that are known case of lipid related disease tested for lipid profile within 15 days of participation. 2. All genders, ethnicity 3. Age Group: 18 to 75years 4. Participant who has given informed consent for participating in this study 5. Participant must be fully vaccinated for COVID 6. Participant must use smart breath analyzer at fasting condition. If not fasting, there should be a minimum gap of 1 hour between consuming water and testing, and 3-4 hours between consuming food and testing.

Exclusion criteria

Exclusion criteria: 1. Individual less than 18 or above 75years of age 2. Pregnant and lactating females 3. Known case of ongoing illness such as a. Cancer b. AIDS c. COVID d. Cough, Fever e. TB f. Chickenpox g. Influenza h. Mumps i. Tonsil 4. Individual who has not given informed consent for this study

Design outcomes

Primary

MeasureTime frame
1. Development and validation of IoT & Deep tech enabled smart breath analyzer for accurate and early screening of metabolic derangements such as diabetes, kidney issues, liver issues lung and lipid issues. 2. AI and ML based affordable, non-invasive and effective option for prophylaxis and healthcare. 3. Effective and early screening of underlying health issues in an individual to enable timely preventive action.Timepoint: Baseline

Secondary

MeasureTime frame
Measurement of Total cholesterol Triglycerides HDL VLDL LDL Cholesterol/ HDL Ratio LDL/HDL Ratio Liver Function Kidney Function Blood sugar and compare with levels of critical compounds measured by smart breath analyzer device.Timepoint: baseline

Countries

India

Contacts

Public ContactSuchita Kanaldekar

Humors Tech Pvt Ltd.

suchita@humorstech.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026